Randox Food Diagnostics are attending AOAC Denver 2019
Randox Food Diagnostics are attending AOAC Denver 2019
Randox Food Diagnostics are exhibiting at AOAC in Denver. Various contaminants are administered to animals during the farming process to treat infection and maintain herd health. Regulations are often adhered to, as quality control procedures are put in place to ensure the safe supply of agricultural produce and this is where Biochip technology can streamline the quality control process. By offering a system that can analyse up to 48 sample simultaneously, our technology delivers higher throughput which in turn saves time and money on laboratory costs and labour.
Randox Food and Biochip Array Technology
Biochip Array technology (BAT) is designed with the aim of revolutionising the screening practices of your laboratory. Designed to work across a wide variety of matrices, BAT uses a micro-spotting technique to create an assay that can detect and provide quantitative results for up to 44 residues from a single sample.
The market leading 9mm x 9mm ceramic chip brings the capacity to detect the range of antibiotics, anti-parasitic, anti-inflammatory, growth promoting and mycotoxin residues simultaneously in a range of food and feed samples.
AOAC’s annual meeting is taking place this September in Denver. The meeting organises scientific sessions, roundtable discussions, workshops and poster presentations discussing a variety of analytical methods and requirements. Attended by scientists from across the world the conference discusses science at a different level.
At AOAC Denver you will get the opportunity to speak to our experts on the Biochip Array Technology. By visiting booth #416 you will get an introduction to BAT and find out how the technology can perfectly fit any of your screening needs.
To learn more about Biochip Array Technology contact firstname.lastname@example.org or stop by Booth #416 at AOAC Denver 2019 and chat the Randox Food team!
Find out more about AOAC.
Want to know more?
Contact us or visit our Randox Food Diagnostics website.
Meat & Seafood
The prevalence of drug addiction and abuse across the globe has become a growing concern. It is currently estimated that 71 million people use drugs of abuse with around 166,000 direct deaths occurring from drug use in 2017.
The WHO (World Health Organisation) estimate that 11 million people inject drugs across the globe, of which 1.3 million are living with HIV, 5.5 million with hepatitis C, and 1 million with both HIV and hepatitis C. In addition to infectious disease, long term drug abuse increases the risk of several cancers, cardiovascular effects, respiratory effects, gastrointestinal effects, kidney & liver damage and mental health issues.
The abuse of drugs is one of the most pressing issues in the USA and other countries globally. Drug abuse not only affects the individual, but can also have far-reaching consequences that affect family, employment, personal health, health care systems, local communities, and society as a whole.
Global Drug Abuse – The buzz that keeps on going!
> Misuse of illicit drugs affects society through secondary costs incurred such as crime, reduced productivity at work, and health care expenses.
> Substance abuse costs the US health care system about $11 billion, with overall costs reaching $193 billion.
> Substance abuse and addiction also affects other areas of life leading to broken families, destroyed careers, death due to negligence or accident, domestic violence, physical abuse and child abuse.
> Drug abuse and addiction changes the chemistry of your brain. The longer an individual abuses drugs, the more damage is caused, making it more difficult to return to ‘normal’ during drug rehabilitation.
> Treating and tackling drug addiction is a challenge. As drug treatment and health services continue to fall short, there is an increased need to continuously adapt drug detection and analysis.
Randox laboratories are at the forefront, aiding the fight against drugs of abuse with a comprehensive range of 10 drugs of abuse assays including several stimulants, sedatives and opioids available to run on Randox’s very own clinical chemistry analysers, the RX series. To find out now how Randox is helping to tackle the ongoing prevalence of drugs of abuse click here or buy directly from the Randox Online Store.
About Randox Laboratories
As a world leader in the in-vitro diagnostic industry with over 35 years’ experience, Randox is leading the charge in moving from a one-size-fits-all approach towards decisions, practices and products tailored to the needs of the individual. This innovative approach to diagnostics has facilitated the development of revolutionary products designed specifically to enhance a patients’ quality of life.
Want to know more?
Contact us or visit our Drugs of Abuse pages to learn more.
Therapeutic Drugs Monitoring
At Randox Testing Services our workplace drug & alcohol testing programs are designed with the customer in mind. We tailor our packages to ensure that every company has the testing program in place that suits the needs of their business. We find that no two companies have the same requirements. What works for one may not necessarily work for another, so our experience in helping companies craft tailored packages has afforded us knowledge that has allowed us to build long-term customer relationships.
Have a read below about how we help companies across various markets in their efforts to provide safer workplaces by reducing the impact of drugs & alcohol.
Workplace Drug & Alcohol Testing
With the widespread availability of drugs and alcohol, there is an increased risk of substance abuse in the workplace leading to huge ramifications for a business and its employees. Jeopardising the safety of not only the user, but also their co-workers and in some cases the public, it affects the whole business environment and puts those present at serious risk of harm.
It is estimated that 1 in 20 people aged between 15-64 used an illicit drug in the past year. What’s more concerning is that 10% of these people are considered to be problem drug users. In the UK, it is estimated that £7.3 billion is lost each year due to the amount of lost work and productivity through alcohol abuse alone.
To counteract the negative effects substance misuse can have on a company, many organisations implement a policy that outlines their expectations concerning working whilst under the influence of alcohol and drugs. Employers hold the responsibility to ensure employees are fully aware of the company’s rules, regulations, testing and disciplinary procedures.
Our complete testing solutions ensure companies are provided with the necessary support and information in their efforts to implement workplace testing. Our drug & alcohol testing experts can provide information on sample types, types of testing, policy and drugs we test for; all of which are designed to ensure needs and requirements are met.
Medico-Legal Drug & Alcohol Testing
Medico-legal testing for drugs and alcohol may be required by various professional bodies involved in child custody cases, care proceedings or child protection cases. Drug & alcohol testing is important to ensure child protection from the detrimental effects of parental substance misuse and to ensure they have a quality of life they deserve.
At Randox Testing Services we provide drug & alcohol testing to all professionals within the family law and medico-legal sector. Our hair drug testing service utilised accredited testing methods and is made more cost-effective through the patented testing methods we have developed.
Our drug and alcohol testing solutions are flexible and can be tailored to our customer needs with a choice of testing methods. We offer a comprehensive drugs of abuse test menu and our service also includes expert witness reporting where applicable.
Randox Testing Services
Want to know more about the drug & alcohol testing services we offer for workplaces and professionals in the medico-legal sector? One of our experienced business development executives will be happy to discuss your requirements. Contact us using any of the below methods.
Tel: +44 (0) 28 9445 1011
Staff Newsletter April - June 2019 Edition
We are delighted to be able to share with you the Q2 2019 edition of our We Are Randox staff newsletter!
Click here for a range of company and staff news from April to June 2019 – including photographs from the Randox Health Grand National 2019 and all our staff fundraising for AWARE NI and Mind Your Mood.
** Please note that image links work most efficiently in your Google Chrome browser**
Recent studies have found harmful water and food contamination throughout China due to the country’s large use of antibiotics.
In June 2006 an infant receiving treatment for a fungal infection and pneumonia in Guangzhou City was found to be infected with a kind of super bacteria resistant to seven types of antibiotics. The Epoch Times reported that Dr. Song Yanyan, who was involved in the treatment, told Chinese media Sina that nowadays many newborn babies are found to be carrying super bacteria. In antibiotic susceptibility tests, 70% of newborns were found to show resistance to one or more antibiotics, a huge increase when compared with previous figures.
Epoch times reported that; Dr Ying – lead researcher of antibiotics at the Guangzhou Institute of Geochemistry, led a research team all over China to investigate the scale of antibiotics consumption and discharge into the environment. They produced an “antibiotics pollution map” and the findings were that in 2013 alone, 162,000 tons of antibiotics were consumed in China—52% for veterinary treatment, and 48% for human treatment. The researchers mainly focused on 36 types of the most commonly detected antibiotics. The annual consumption of these antibiotics was more than 90,000 tons, of which 84% was given to livestock.
It was found that because of the large number of animals in pig and chicken farms, farmers have been adding a variety of antibiotics to the feed to reduce the chances of infectious diseases. Similarly, aquaculture farmers often add antibiotics when feeding fish, shrimp and crab. The export of these chicken, fish and seafood products from China pose health concerns for consumers because of their high antibiotic levels.
In order to help the industry, Randox Food Diagnostics developed the revolutionary multiplexing Biochip Array Technology, allowing the screening of up to 54 individual meat, seafood, feed or cereal samples for multiple drug residues, growth promoters and toxins on the Evidence Investigator analyser in under 2 hours and 30 minutes. This high throughput allows the user to save on time and consolidate costs in comparison to confirmatory laboratories.
For more information, contact us by email at email@example.com.
Coronary Heart Disease (CHD) is an illness where plaque builds up inside the coronary arteries. The arteries play an important role in supplying oxygen-rich blood to the heart muscles, however, over time plaque builds up and can harden. This results in the arteries becoming narrow due to not being able to deliver enough oxygen-rich blood to the heart which causes angina or a heart attack to occur.1
BHF highlighted that Coronary Heart Disease was one of the UK’s biggest killers in 2010 resulting 46,000 premature deaths of which 68% were men.2
CHD is more likely with increasing age, particularly in men. These risk factors cannot be changed, however, there are other risk factors that can be modified such as blood cholesterol, being overweight or obese, smoking, lack of physical activity, unhealthy diet and stress.
You can prevent and control many CHD risk factors with heart-healthy changes and medication. Some lifestyles often increase the chance of developing the disease such as smoking, poor diet, adequate exercise therefore, there are many lifestyle changes to help control several CHD risk factors at the same time, such as physical activity which may reduce stress, lower your blood pressure, help control diabetes and help control your weight.3
Currently, there are four state of the art, fully functional ISO12025 accredited laboratories, located in Liverpool, London, Holywood and the Randox Science Park in Antrim giving RCLS the power to output to pharmaceutical, health and research markets.
Specialising in biomarker and multiplex testing in addition to standard safety and clinical testing, RCLS provides a full laboratory service to accelerate laboratory projects to completion. Our experienced project management teams are available to provide support and guidance from initial biomarker selection through to the design of a comprehensive results data package to deliver against your project aims and timelines.
Renowned for quality and reliability, the Rx Series and Evidence series are utilised by all RCLS Laboratories, guaranteeing real cost savings as well as highly-accurate flexible testing solutions. Furthermore, RCLS perform sample testing on numerous third-party analysers situated in our laboratories dependent upon the testing which is required by the customer.
RCLS can outsource the Cardiac Risk Prediction Array in their laboratory on the Evidence Investigator. We developed a rapid array which will allow all 19 SNPs to be genotyped simultaneously on one single sample. The RCLS team aim to save your laboratory time and money. By utilising our multiplex panels including the Cardiac Risk Prediction Array Panel, RCLS can offer labour saving, time reducing and cost-effective solutions for all your laboratory testing.
If you would like to find out more information about RCLS and what it has to offer contact firstname.lastname@example.org
A Queen’s University Belfast student has won the top spot in global healthcare diagnostics company Randox Laboratories’ annual Student Placement Awards.
Pearce Allingham from Andersonstown, who is studying Medicinal Chemistry, was not only placed first in the Science category but was also crowned Best Overall Placement Student.
Since September 2018, Pearce had been working alongside the scientific team in the New Technology Evaluation department, taking part in the development of Randox’s newest and most classified innovations.
Speaking at the awards ceremony at Randox Laboratories HQ in Crumlin on Friday 14th June 2019, Pearce commented,
“I’m so pleased to have won this award. I couldn’t recommend a placement at Randox highly enough and it has allowed me to see what I’m capable of when I apply myself to a field I’m passionate about. From day one I was made to feel like a scientist within the team – not just a placement student – and it’s amazing that some of my contributions are helping to advance Randox’s diagnostic capabilities further. I look forward to applying my new knowledge and skills in final year and to forging a career in research – maybe even back here at Randox.”
Randox Laboratories welcomes over 60 placement students through its doors each year across Science, Engineering and Business-related disciplines, including Sales and Marketing. The company is keen to continue to maintain its reputation as a key placement provider in Northern Ireland, as explained by Linda Magee, Operations Director at Randox Laboratories.
“We host many high calibre placement students at Randox each year and the Randox Placement Awards is the pinnacle in highlighting the fantastic contribution that these students make. Pearce, in particular, impressed us with his work ethic and initiative in one of Randox’s most cutting-edge R&D teams. Gaining industry experience is vital for young people and that is why we pride ourselves on the range of placement opportunities we provide here, especially through the Randox APEX programme which offers students a paid summer placement between first and second year, a paid placement year in third year and, finally, a graduate position on completion of their degree with a 2:1 classification. It really is the complete career package for any aspiring student.”
David Boyd, a QUB Engineering student from Belfast, won in the Engineering category of the Randox Placement Awards while Andrew Wilson, an Ulster University student from Bangor, was placed first in the Business category.
David Boyd, Engineering Placement Award winner, commented,
“As part of the Engineering team, the opportunities I’ve been given here have been second-to-none and I look forward to completing my Master’s degree in Mechanical Engineering. I used to think I would go on to work in the energy sector with renewables and nuclear but my time in Randox has shown me a different industry which I would love to return to.”
Andrew Wilson, Business Placement Award winner, also said,
“Being given the same responsibilities as the rest of your colleagues is a great way to learn quickly as you get immersed in live projects and real business. One of the most interesting aspects for me was the opportunity to travel to Hamburg and Chicago for customer visits and conferences. Dealing with different departments such as manufacturing, finance and logistics, along with my own sales and marketing team, has given me an insight in to the workings of an international company which has been an invaluable experience.”
Randox Placement Awards 2019 results
1 Andrew Wilson (Marketing, Randox Food Diagnostics), an Ulster University student from Bangor
2 Kathryn Wilson (Sales, Randox Biosciences), an Aberystwyth University student from Larne
3 Adam Donnelly – (Marketing, Randox Corporate), an Ulster University student from Bellaghy
1 Pearce Allingham (Chemistry), a Queen’s University Belfast student from Andersonstown
2 Rachel McCloy (Biotechnology), a Liverpool John Moore’s University student from Ballymena
3 Thomas Smith-Zaitlik (Molecular), a Nottingham Trent University student from Henley-on-Thames.
1 David Boyd (Engineering Design, Mechanical), a Queen’s University Belfast student from Belfast
2 Reuben Cotton (Engineering Design, Mechanical), an Ulster University student from Lisburn
3 Niall Devlin (Engineering Design, Software)
Overall Randox Placement Awards winner: Pearce Allingham
For further information please contact the Randox PR team by emailing email@example.com or phoning 028 9442 2413
What is Familial Hypercholesterolemia?
Familial Hypercholesterolemia (FH) is a genetic condition which is passed down from the parents’ genes. The British Heart Foundation has highlighted that FH is caused by a genetic mutation which means the liver is unable to remove excess ‘bad’ cholesterol (LDL), therefore, the LDL level in the blood remains high.2 Someone who suffers with FH would have high cholesterol from birth which can cause other health issues including heart and circulatory disease.
Heart UK states that more than 260,000 people in the UK may have FH. However, less than 10% of this number have been diagnosed and therefore, may not be aware of their condition.3 However, to date there are no clear symptoms if someone has FH until it is considered too late.
Familial Hypercholesterolemia (FH) symptoms
- Swollen tendons/fatty lumps on the knuckles of your hands, at the back of your ankles and knees
- Cholesterol deposits around the eye-lids (looks like pale and yellowish patches)
- Grey-white cholesterol deposits around the corneas
If untreated, about 50% of men and 30% of women with FH will develop coronary heart disease by the time they are 55. More worryingly, on average in the UK, one person a day with FH has a heart attack. About a third of people don’t survive their first heart attack, and many who do survive will have damaged hearts.
The good news is that a 2008 study part-funded by the BHF found that people with FH who are diagnosed and treated before they develop heart disease generally live as long as people who don’t have FH. That’s why it is vitally important to get diagnosed as early as possible.
How Randox Biosciences can help
Randox Biosciences offers the Familial Hypercholesterolemia (FH) Arrays I & II to help encourage early diagnosis with rapid turnaround time. This allows results to be reported within days compared with NHS waiting lists which can be substantially longer.
Our two arrays are rapid, simple and accurate which enables the simultaneous detection of 40 FH-causing mutations (20 mutations per array) within the LDLR, ApoB and PCSK9 genes.
The mutational status can be determined rapidly from a single test, with a reduced need for confirmatory testing. Genetic analysis for FH mutations also allows for more accurate diagnosis compared to lipid profiling.
Familial Hypercholesterolemia (FH) Arrays I & II:
LDLR – 38 mutations
APOB – 1 mutation
PCSK9 – 1 mutation
To find out more about the products that we offer, email us firstname.lastname@example.org
A huge congratulations is in order for Science Higher Level Apprentice Sarah Casey who battled it out at the NI WorldSkills Regional Heat on 4th June to be awarded a well-deserved second place.
This was the first WorldSkills NI Regional Heat for Laboratory Technicians and was hosted at Southern Regional College, the Life Sciences Hub for Further Education in Northern Ireland.
The laboratory technician competition is based on real life scenarios in science that demonstrate technical competence in the use of complex instrumentation, laboratory equipment and skills. The competition is designed to reflect the work of a laboratory technician and tests their skills in techniques and procedures to solve practical problems through analysis, tests and measurements while ensuring safe and ethical working practices.
“This regional heat was a fantastic opportunity for higher education students across the sector to showcase their technical and analytical abilities. The competitors have performed exceptionally well under such challenging conditions” said Dr. Asha Jamil, Life Sciences Hub Development Manager at Southern Regional College.
She continued; “Judges have come from a variety of specialist scientific backgrounds from both education and industry across the UK and I am delighted that competitors from NI had this opportunity to demonstrate their range of skills on such a prestigious platform. Judges also commented that they were highly impressed by all the competitors’ technical and analytical skills and their professional approach to this challenging competition.”
Judges were representatives from Middlesex University, Norbrook Laboratories, and also included the current Team UK Laboratory Technician winner, Tonicha Roberts, who is a Forensic Reporting Scientist with Eurofins Forensic Services, UK.
Competitors came from a range of higher education programmes from across the NI sector including Foundation Degrees and Higher Level Apprenticeship (HLA) programmes. The HLA students study their underpinning Ulster University Foundation Degrees at Southern Regional College (Newry and Portadown campuses) and are employed with Norbrook Laboratories, Randox and Almac.
Sarah Casey, who was awarded second place, is currently a Southern Regional College student completing the Higher Level Apprenticeship in Applied Industrial Sciences (Life Sciences Pathway) in the Randox Science Park in Antrim. Sarah also won Southern Regional College’s Science Competition in January 2019.
The top performing competitors across the UK will now have a nail-biting wait to see if they have scored high enough to qualify for the WorldSkills UK Final at Birmingham’s NEC in November. We wish Sarah the best of luck!
At Randox Testing Services, we are always trying to think of new ways to get the message across about the positive impact workplace drug & alcohol testing can have on an organisation. So, we decided to speak with one of our colleagues; Simon Tibbo, who is regularly engaging with companies about how to be proactive in minimising the risks of substance misuse.
Read below to find out what he had to say.
From your experience and knowledge, what industries are currently implementing testing programmes?
Apart from the finance industry, I’ve personally seen testing programmes within almost all business sectors, from the obvious, safety critical industries, Rail Track, Maritime, Construction, Logistics, all the way through to manufacturing firms, retail outlets, and even predominantly clerical companies. If a company has a workplace substance misuse policy and are looking to satisfactorily enforce the terms within, they will be engaged with a service provider, such as Randox, to properly support the policy.
What are, in your opinion, the barriers that companies face when trying to implement working drug & alcohol testing?
The introduction of a substance misuse policy to an already existing ‘company handbook’ can be a challenge, especially if the work-force has been established for some time. People don’t tend to like change, especially within the workplace. Unions can sometimes be unwelcoming to the idea of random testing and will often look to restrict the scope of testing or the policy itself. I’d say that each industry/company will likely meet its own barriers whilst developing and implementing a policy, and some may well be unique to the individual circumstances. Often, customers may implement an amnesty period prior to the commencement of a drug testing programme. This gives employees the opportunity to come forward and declare if they have a substance misuse issue which they can address together with their employer without sanctions.
Why has there been a delay in some companies developing workplace policies that directly relate to substance misuse?
There could be many reasons as to why a company hasn’t implemented a policy, but I’d expect somewhere near the top of that list would be either the assumption there isn’t a substance misuse issue within the business/industry, the worry that a substance misuse issue within the business/industry is highlighted by the introduction of a policy, and therefore creating more problems than its seen to be solving, or even that a company is simply unaware the solution is available and beneficial.
How important within a policy is it that a company clearly outlines what is expected of an employee, and the consequences of substance misuse?
Very! A policy needs to be clear and concise in its structure and procedures. If you aren’t explaining the terms or the consequences you could potentially end up with a problematic HR process and unresolvable tribunal cases. If an employee has sight of a straightforward policy they will know what to expect if the terms are breached, not to mention enforcing it should be equally as straightforward. It is also important to state why the policy is in place – i.e. to protect the workforce, the public and the company reputation.
Is it important to state cut-offs in substance misuse policies?
For alcohol, yes, most certainly. For drugs, not so much. An alcohol test with a home office approved breathalyser will provide an evidential result, which can be directly related to a ‘site cut-off’ (in the same manner as the existence of a road legal limit). Workplace drug testing should adhere to specific guidelines set-out by the EWDTS (European Workplace Drug Testing Society) in not just it’s procedures, but also its expected substance cut-offs. The cut-offs differ between substances so it’s not quite as straightforward. My suggestion would always be, if you feel it necessary to include drug cut-off information, refer to the EWDTS guidelines, they’re available to download on the EWDTS website if anyone needs sight, but ensure your provider is working to them and don’t go into full details, it’ll serve only to add unnecessary bulk to what should ideally be a streamlined policy.
How effective has workplace testing been in helping companies reduce the risk of drug & alcohol use?
From personal experience I can tell you, I’ve seen companies implement a policy/testing practice due to an awareness of substance misuse, only to reduce the volume of testing over time as the approach has proved successful in reducing or eradicating the specific problem. I’d say that’s a testament to implementing a random testing practice, it sends a sensible message in a fair and balanced manner, which ultimately gets results. If it’s done right, it’s going to be beneficial, even if it’s not particularly well received at its inception. Other examples where testing volume has been scaled back have led to an increase in the rates of positives demonstrating that an active testing programme is a deterrent to substance misuse.
Going forward, what industries do you see adopting a more proactive approach in use of substance misuse testing?
Likely most industries, every company has a duty of care to staff, contractors, visitors and/or the public. There will always be industries that don’t agree, don’t want to uncover issues or don’t believe they exist, but it’s the people that matter and the more that’s done to promote safety, welfare and overall good practice, the more industries will settle to the idea.
About Randox Testing Services
Randox Testing Services offer a wide range of products and services for the testing of illicit substances. We can craft customised packages to suit the needs of our customers, no matter what the industry.
Our expertise and experience working within this industry allow us to provide a range of testing solutions that will impact the risk of substance use in the workplace. With an extensive collection network and quality products, we can meet the needs of your business.
To find out more, contact us:
Phone: +44 (0) 28 9442 2413